Cardiovascular disease (CVD) continues to be the leading cause of death globally and has an enormous impact on public health and the healthcare delivery system. The goal of the partnership between the two companies is to develop solutions that will address this global challenge by improving the cost, access to and the quality of cardiac care.

"CT can be a viable, minimally-invasive imaging alternative for many cardiovascular procedures," said Steve Gray, VP and General Manager for GE Healthcare Global CT and Advantage Workstation. "We chose Arineta as a partner because we believe their cardiovascular imaging technology complements the GE Healthcare market-leading position in CT imaging."

Yosi Morik, Arineta co-founder and Chairman commented "We believe this collaboration with GE Healthcare provides the most effective path for Arineta to bring its cardiovascular imaging technologies to market."

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $16 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

About Arineta Ltd
Arineta Ltd., based in Caesarea, Israel, is a privately owned start-up company focused on the development of advanced imaging systems for cardiovascular diagnosis and therapeutic applications. Arineta's mission is to develop clinically effective, reliable and safe solutions for cardiovascular imaging. Arineta systems are being developed to provide clear, sharp and accurate images - while optimizing dose, reducing discomfort to the patient, and lowering the cost of healthcare delivery. For more information about Arineta, see www.arineta.com.